A 48-year-old woman with type 1 diabetes mellitus for 15 years presents with sudden onset of floaters and blurred vision in the left eye. She has no pain or photophobia. Her HbA1c is 8.1%. On examination, visual acuity is hand movements in the left eye. Dilated fundoscopy reveals extensive dot-blot and flame-shaped hemorrhages, venous beading, multiple areas of cotton-wool spots, and prominent intraretinal microvascular abnormalities (IRMA). No neovascularization is visible. B-scan ultrasonography shows vitreous hemorrhage. What is the most appropriate next step in management?

Explanation

## Management of Severe NPDR with Vitreous Hemorrhage **Key Point:** Severe NPDR with vitreous hemorrhage requires a staged approach: first stabilize the retinal disease with panretinal photocoagulation (PRP), then address the hemorrhage with vitrectomy if it does not clear spontaneously. ### Staging and Severity Assessment This patient has **severe nonproliferative diabetic retinopathy (NPDR)** based on: - Extensive hemorrhages (dot-blot and flame-shaped) - Venous beading - Cotton-wool spots - Prominent IRMA - Absence of neovascularization (not yet proliferative) **High-Yield:** The **Early Treatment Diabetic Retinopathy Study (ETDRS)** established that PRP is indicated for severe NPDR even in the absence of neovascularization, because the risk of progression to proliferative DR within 1 year is >50%. ### Management Algorithm for Severe NPDR + Vitreous Hemorrhage ```mermaid flowchart TD A[Severe NPDR + Vitreous Hemorrhage]:::outcome --> B{Can retina be visualized?}:::decision B -->|Yes| C[Perform PRP immediately]:::action B -->|No| D[Perform PRP with indirect laser or trans-pars plana approach]:::action C --> E[Review in 3 months]:::action D --> E E --> F{Hemorrhage cleared?}:::decision F -->|Yes| G[Continue observation, manage glycemia]:::action F -->|No| H[Vitrectomy]:::action H --> I[Post-vitrectomy PRP if not done]:::action ``` ### Why PRP First? 1. **Prevents progression to PDR** — PRP reduces the risk of neovascularization by destroying ischemic peripheral retina that produces VEGF. 2. **Improves visualization** — Regression of hemorrhages is more likely after PRP because the underlying ischemic drive is eliminated. 3. **ETDRS evidence** — PRP for severe NPDR reduces the risk of severe vision loss by ~50% [cite:ETDRS Report 10]. **Clinical Pearl:** In cases where the retina cannot be visualized due to dense vitreous hemorrhage, PRP can still be performed using **trans-pars plana approaches** or **indirect laser delivery**, or vitrectomy can be performed first to clear the hemorrhage and allow better visualization for subsequent PRP. ### Timing of Vitrectomy - **Immediate vitrectomy** is NOT indicated unless: - Dense hemorrhage persists >3 months - Traction retinal detachment threatens the macula - Neovascularization is actively bleeding and cannot be controlled with PRP - **Wait 3 months** for spontaneous clearance in most cases, as many vitreous hemorrhages reabsorb naturally. **Mnemonic for Severe NPDR Management:** **P-then-V** = **Panretinal photocoagulation first**, then **Vitrectomy** if hemorrhage persists. ### Why Not the Other Options? **Immediate vitrectomy (Option A):** Premature. Vitreous hemorrhage often clears spontaneously within 3 months. PRP must be done first to prevent progression to PDR. **Anti-VEGF alone (Option C):** While anti-VEGF agents are useful in PDR and diabetic macular edema, they are not first-line for severe NPDR. PRP remains the gold standard for severe NPDR. **Focal laser (Option D):** Focal laser is used for diabetic macular edema (hard exudates threatening the macula), not for severe NPDR. This patient's hemorrhage is extensive and not localized to the macula.